Next Article in Journal
HER2-Low and HER2-Ultralow Metastatic Breast Cancer and Trastuzumab Deruxtecan: Common Clinical Questions and Answers
Next Article in Special Issue
Clinical Importance of Molecular Biomarkers in Pleural Mesothelioma
Previous Article in Journal
Therapeutic Applications of Fibroblast Activation Protein (FAP)-Binding Radiopharmaceuticals: Review of Opportunities and Challenges
Previous Article in Special Issue
Circulating Biomarkers and Targeted Therapy in Pleural Mesothelioma
 
 
Review

Article Versions Notes

Cancers 2025, 17(24), 4020; https://doi.org/10.3390/cancers17244020
Action Date Notes Link
article html file updated 17 December 2025 11:36 CET Original file https://www.mdpi.com/2072-6694/17/24/4020/html
article pdf uploaded. 17 December 2025 11:34 CET Version of Record https://www.mdpi.com/2072-6694/17/24/4020/pdf
article xml uploaded. 17 December 2025 11:34 CET Update https://www.mdpi.com/2072-6694/17/24/4020/xml
article xml file uploaded 17 December 2025 11:34 CET Original file -
Back to TopTop